In contrast, they considered that obesity might be a risk factor for the development of pancreatitis and pancreatic cancer (223)
Patients should never change the dose, stop or restart treatment without medical advice
However, more rigorous, controlled studies are necessary to determine whether GLP-1 medications are truly responsible
10.2337/db09-1297 Diabetes 128 PedersenJ.PedersenN
Tirzepatide comes in six dosage strengths, ranging from 2.5 mg to 15 mg, for diabetes management, weight loss, and the treatment of sleep apnea
If youre off of the drugs for several weeks, then you may have lost the ability to tolerate the side effects and you might need to start at a lower dose, Low Wang said